3Daughters
Gary Shangold is the Chief Medical Officer at 3Daughters and the CEO at InteguRx Therapeutics, a start-up specialty pharmaceuticals company. He also serves as the President of Convivotech LLC, a consultancy to the Life Sciences industries. In the past, he held roles such as Chief Medical Officer at Enteris BioPharma Inc and Xanodyne Pharmaceuticals. With a background in medicine and pharmaceuticals, Gary has also served as President of NovaDel Pharma and the American Academy of Pharmaceutical Physicians. Additionally, he has held academic positions at Harvard Medical School and Massachusetts General Hospital. Gary holds a Doctor of Medicine degree from Columbia University and has completed specialized training in the field of Obstetrics & Gynecology.
This person is not in any teams
3Daughters
3Daughters is a clinical development company focused on Evolutionary Healthcare for Women. Our first evolution is a frameless, magnetic, nonhormonal intrauterine device (IUD) based on physics and geometry for long-acting contraception. Our unique IUD was designed to improve upon the outdated T-shape frame of current IUDs that causes pain, perforation and expulsion. These problems lead to a ‘fear factor’ for women and practitioners inserting the device. Current IUDs also require dangling strings for retrieval- a nuisance factor for women and their partners. 3Daughters newly designed IUD conforms naturally to a woman’s body and will address the 'fear factor', pain and other problems of current IUDs …with no strings attached! Nearly all women use contraception in their lifetimes, and we plan to make it better.